Independent COVID-19 Guides, Resources and Protocols - Reducing Risk of COVID-19 Infection and Severity
Hyperbaric Oxygen Therapy for Long COVID and Post COVID Vaccine Symptoms
Get link
Facebook
Twitter
Pinterest
Email
Other Apps
By
Dr Frank Yap, M.D.
-
“When I first heard about it [HBOT] I thought, ‘this is goofy,’” said Dr. Paul Marik. Then he encountered a competitive cyclist patient who became bedridden after COVID vaccinations. “He was completely incapacitated. He went for hyperbaric oxygen [and] within about five or six sessions [he] was back on his bicycle.”
Marik, co-founder of the Front Line COVID-19 Critical Care Alliance (FLCCC), told The Epoch Times, that some patients who have spike protein injuries have responded particularly well to hyperbaric oxygen.
Dr. Paul Marik, co-founder of the Front Line COVID-19 Critical Care Alliance (FLCCC) and former Chief of the Division of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School, at the FLCCC conference “Understanding & Treating Spike Protein-Induced Diseases” in Kissimmee, Fla. on Oct. 14, 2022. (The Epoch Times)
How Does HBOT Work?
Hyperbaric oxygen therapy (HBOT) involves patients breathing in 100 percent pure oxygen in a chamber at an atmospheric pressure higher than normal sea level (1 standard atmosphere, or ATM).
Since oxygen normally only makes up around 21 percent of air, the increased pressure of pure oxygen would further increase oxygen levels in the blood.
Depending on the pressure administered, blood oxygen levels can be increased to three times the normal level.
The treatment is mostly used for wound healing, including both internal and external wounds.
Cells need oxygen to function. The mitochondria uses oxygen to break down sugars into energy, so increased blood oxygen levels drive tissue growth and regeneration. Increased oxygen levels also clear bacterial infections.
HBOT is currently approved as a treatment for 15 different wounds and health conditions including carbon monoxide poisoning, tissue damage, blood loss, burns, skin grafts, soft tissue infections, and intracranial abscesses.
Outside of the United States, Russia lists 70 diseases that can be treated by HBOT, China lists 49, and Japan lists 33.
Dr. Paul Harch, a renowned HBOT expert and founder of Harch Hyperbarics, said at the FLCCC conference in Kissimmee, Florida that a major underlying pathology of wounding is inflammation; HBOT repairs wounding by reducing inflammation and promoting regrowth.
Since inflammation is an underlying pathology for many diseases, this makes HBOT conceptually applicable for various conditions, even wounding from diabetes, which is a metabolic disease driven by inflammation.
Epigenetics are factors that change gene activity. Depending on environmental factors including stress, diet, drugs, and treatments, certain genes can be activated or suppressed.
“Surprisingly, it is the increased pressure, rather than the increase in the concentration of dissolved oxygen, that appears to mediate these effects,” the FLCCC doctors wrote in their treatment recommendations.
For HBOT, the higher the oxygen pressure, the greater the change in gene expression, and the higher the general benefit.
Therefore the FLCCC recommends to use HBOT at a high atmospheric pressure. But treatment regimens need to be monitored by a clinician to prevent oxygen toxicity.
An in vitro study on human microvascular cells found that cells exposed to a HBOT treatment at 2.4 standard atmospheres (ATM) for 60 minutes, had changes in gene expression in 8,101 genes 24 hours later.
HBOT increased the expression of anti-inflammatory genes and reduced the activity of pro-inflammatory genes.
Since cells exposed to pure oxygen at normal atmospheric pressure had “minimal change” in their gene expression, this demonstrated that pressure is the key player in the overall therapy.
Another study on rats further indicated the importance of pressure. The study showed that depending on the pressure of the environment, different numbers of genes were expressed.
The authors of the study exposed rats to normal air and pure oxygen at normal atmospheric pressure and higher pressures. The data showed that in rats, as oxygen levels increased from the pressure would cause an increase in gene expression.
Physiological Changes From Hyperbaric Oxygen
HBOT is currently recommended as a third-line treatment for post-vaccine symptoms, coined under the umbrella term of post COVID vaccine syndrome.
FLCCC doctors reason that both long COVID and post-vaccine symptoms are driven by a chronic exposure to spike protein, which promotes immune dysregulation and inflammation, this therefore makes conceptual sense that HBOT may work as a potential treatment.
Studies showed that HBOT could reduce inflammatory pathways and reduce the action of pro-inflammatory toll-like receptor pathways, both of which are often activated in acute COVID infections and spike protein-induced diseases.
Mitochondria are responsible for breaking down the sugar we ingested through our food, into energy, and uses oxygen as a key reactant of this biochemical process.
During inflammation experienced in long COVID and post-vaccine syndromes, the spike protein can stress the mitochondria in the cell, leading to reduced energy production and more production damaging radical species. Therefore the extra oxygen provided through the treatment gives ample material for use by the mitochondria to increase energy production for the body.
HBOT also induces the release of stem cells and tissue growth factors.
Many studies found the treatment to be beneficial in promoting tissue regeneration including the regeneration of muscle cells and generation of new blood vessels, this indicates that HBOT can help in the repair of tissue damaged from spike protein injuries.
Neurological symptoms are some of the major symptoms in long COVID and post-vaccine symptoms. There are also studies that showed that HBOT enhanced neurogenesis, though HBOT has not been approved by the Foods and Drug Administration for such treatment yet.
Harch has had successes in treating wounds in the brain including a near-reversal of brain damage in a drowned 2-year-old girl in 2017.
The girl had suffered from a deep brain injury and had “no speech, gait or responsiveness to commands with constant squirming and head shaking” he said.
But following 40 sessions, the girl had near-normal motor function, normal cognition, gait, and temperament, and improvement on nearly all neurological exam abnormalities. Her speech improved to a greater level than pre-drowning and she also discontinued all of her medications, according to the LSU Health New Orleans School of Medicine media release.
Studies have also found HBOT treatments increased blood flow and induced microstructural changes; this led to improved brain function including cognitive functions, gait, and sleep.
HBOT for Spike Protein-Induced Diseases
Studies on HBOT therapies have shown it to be beneficial against COVID and long COVID. There is much literature on HBOT that find positive outcomes in treating COVID infections.
All of the COVID patients presented low oxygen levels, rapid breathing, and inflammatory markers. After one to six sessions of HBOT, inflammatory markers fell and the rapid breathing ceased.
“Most importantly, HBOT potentially prevented the need for mechanical ventilation,” the authors wrote.
In a randomized controlled study from Argentina, HBOT was used to treat for low oxygen in COVID-19. The study was stopped after the interim analysis of 40 patients’ outcomes. The differences between the treatment and the non-treatment group were obvious.
Patients under treatment for HBOT improved their blood oxygen levels in three days, compared to the non-treatment group which took 9 days.
In particular, studies on long COVID showed that HBOT has significant improvements on fatigue, and brain fog by improving attention, memory, information processing, and mental health.
In an Israeli study published in July 2022 on 73 long COVID patients, half (37) were treated with HBOT and the other half (36) with placebo. The patients received treatments five times a week and the protocol included breathing pure oxygen by mask at 2 ATM for 90 minutes.
The authors noticed improvements in the HBOT treatment group in global cognitive function, attention, and executive function, with significant improvements in energy, sleep, mental health, and reduced pain.
Brain scans of these patients further showed improved blood flow in certain areas of the brain, suggestive of blood vessel formation.
The FLCCC recommends HBOT as a third line treatment as it is considered to be a treatment that “may be lifesaving for one patient and totally ineffective for another,” and is therefore less applicable for the general population.
Marik also acknowledged that the high cost of the therapy and differences in pathophysiology may not make the treatment suitable for everyone. They currently recommend HBOT only for severe neuropathologies in patients suffering from post-vaccine syndromes, particularly peripheral neural pain. Contraindications for this treatment include people with untreated pneumothorax.
About the Author: Marina Zhang is based in New York and covers health and science.
Base Spike Detox According to Dr Peter McCullough (in a Twitter post - July 2023): Base Spike Detox is what I am currently using in my practice for those who have had COVID-19 multiple times, one or more of the COVID-19 vaccines, or both and believe persistent SARS-CoV-2 Spike protein could be causing problems in their body. A major publication is under review and editing; however, the information is far too important to hold back. Update: Published on August 25, 2023 in Journal of American Physicians and Surgeons. CLICK HERE FOR THE COMPLETE PAPER > Base Spike Protein Detoxification . I have arrived, based on the emerging scientific literature and my clinical observation, that three OTC products are essential as a triple base combination: Nattokinase 2000 FU (100 mg) twice a day Bromelain 500 mg once a day Nano/Liposomal Curcumin 500 mg twice a day Additional products can be add
Dr. Peter McCullough is an internist, cardiologist, epidemiologist, a full professor of medicine at Texas A&M College of Medicine in Dallas, USA. He also has a master's degree in public health and is known for being one of the top five most-published medical researchers in the United States and is the editor of two medical journals. McCullough Protocol 2022 Updates: Omicron variant XBB found to be resistant to monoclonal antibody treatments ( New England Journal of Medicine . Dec 2022) What really killed COVID-19 patients: It wasn't a cytokine storm, suggests study (2023) Everyone is familiar with nasal and oral swab testing for COVID-19. It should be obvious the virus is replicating in the nose, and with Omicron, the speed of replication has become much greater than the
Well-respected North Texas cardiologist, Dr. Peter McCullough has impeccable academic credentials. He's an internist, cardiologist, epidemiologist, a full professor of medicine at Texas A&M College of Medicine in Dallas. He also has a master's degree in public health and is known for being one of the top five most-published medical researchers in the United States and is the editor of two medical journals. McCullough et al. Reviews in Cardiovascular Medicine, 2020 McCullough Protocol 2022 Updates: Omicron variant XBB found to be resistant to monoclonal antibody treatments ( New England Journal of Medicine . Dec 2022) How to Detox Spike Protein from Body (August 2023) As published in Dr
Is povidone iodine the next ivermectin or hydroxychloroquine? Is there any evidence that povidone iodine can treat COVID-19? Iodine 1% Nasal Spray is part of the FLCCC I-CARE early treatment protocol : Nasal spray with 1% povidone-iodine: 2-3 times a day. Do not use for more than 5 days in pregnancy. If 1% product is not available, dilute the more widely available 10% solution and apply 4-5 drops to each nostril every 4 hours. Use 1 % povidone iodine commercial product as per instructions 2–3 x daily. If 1 %-product not available, must first dilute the more widely available 10 %-solution. To make 1% povidone iodine concentrated solution from 10% povidone iodine solution, one dilution method is as follows: – First pour 1½ tablespoons (25ml) of 10% povidone/ iodine solution into a nasal irrigation bottle of 250ml. – Then fill to top with distilled, sterile or previously boiled water. – Tilt head back, apply 4–5 drops to each nostril. Keep tilted for a few minutes, let drain. - Not recom
Doctors are free to prescribe ivermectin to treat COVID-19, a lawyer representing the U.S. Food and Drug Administration (FDA) said in August 2023. “FDA explicitly recognizes that doctors do have the authority to prescribe ivermectin to treat COVID,” Ashley Cheung Honold, a Department of Justice lawyer representing the FDA, said during oral arguments on Aug. 8, 2023 in the U.S. Court of Appeals for the 5th Circuit. The government is defending the FDA’s repeated exhortations to people to not take ivermectin for COVID-19, including a post that said “Stop it.” The case was brought by three doctors who allege the FDA unlawfully interfered with their practice of medicine with the statements. A federal judge dismissed the case in 2022, prompting an appeal . “The fundamental issue in this case is straightforward. After the FDA approves the human drug for sale, does it then have the authority to interfere with how that drug is used within the doctor-patient relationship? The answer is no,”
SELF-HELP without a Doctor ( source ) Zinc 50 mg daily (can take half twice daily if upset stomach) Quercetin 500 mg twice a day three times a day if sick (switch to HCQ/IVM if available) Vitamin D3 40,000-50,000 for five days Melatonin 5 mg - 20 mg nightly for 14 days stomach) Pepcid 40-80 daily 14 days – women or Cimetidine 400 daily -men Full Aspirin (325 mg) daily one month N acetyl cysteine (NAC) Up to 2000-2400 mg 1-2 days, then 1000-1200 mg for a week Treatment: Latest Prescriptions ( source ) Monoclonal Antibodies: outpatient, FDA approved, early treatment, within 10 days Only. Note and Update: Omicron variant XBB found to be resistant to monoclonal antibody treatments ( New England Journal of Medicine . Dec 2022) HCQ 200 mg twice a day 7 days or IVM (weight based 0.4/kg) 20-36 mg daily 2-5 days Fenofibrate (Tricor – anti-lipid) 145 mg daily (inflammatory/cytokine phase. Antioxidant) Cyproheptadine (Periactin – antihistamine) 4 mg BID for 14 days (cytokine phase) D
Treatment should start based on clinical suspicion as soon as possible, preferably within the first 3 days of symptoms. Perform PCR testing, but do not withhold treatment pending results. 'Early' treatment will make significant difference in outcome as opposed to late treatment. To assist all who are having difficulty finding pharmacists to fill prescriptions for ivermectin or hydroxychloroquine (Plaquenil) for preventing or treating COVID-19 , check out Find a Pharmacy to fill Ivermectin (US). See the directory of professionals in US below. Directory of Doctors (by State) Prescribing Effective Outpatient COVID-19 Therapy USA MULTIPLE STATES (Telemedicine or online consultation) The Wellness Company ( twc.health ) Medical Specialty: Family Medicine, Functional Medicine Supported Protocols: I-PREVENT (COVID Protection), I-CARE (Early at-home treatment), I-RECOVER (Long COVID and Post-Vaccine treatme
Biography Well-respected North Texas cardiologist, Dr. Peter McCullough has impeccable academic credentials. He's an internist, cardiologist, epidemiologist, a full professor of medicine at Texas A&M College of Medicine in Dallas. He also has a master's degree in public health and is known for being one of the top five most-published medical researchers in the United States and is the editor of two medical journals. Personal History Dr. Peter A. McCullough was born in Buffalo, New York, on the 29th of December 1962. During high school, he and his family moved to Wichita Falls in Texas and later settled in Grapevine. He has lived and worked in various parts of the United States, including Washington and Michigan, and he now resides in Dallas, Texas. McCullough Protocol 2022 Dr Peter McCullough Early Treatment Protocol
Dr. Peter McCullough has impeccable academic credentials. He's an internist, cardiologist, epidemiologist, a full professor of medicine at Texas A&M College of Medicine in Dallas. He also has a master's degree in public health and is known for being one of the top five most-published medical researchers in the United States and is the editor of two medical journals. McCullough et al. Reviews in Cardiovascular Medicine, 2020 McCullough Protocol 2022 Dilute Povidone Iodine or Betadine ( a 1% solution) gargling and as a nasal spray on a regular basis twice a day for prevention and then if you have been exposed or are in early stages use at least 4 or potentially 6 times a day. You can also use dilute hydroge
Do nasal sprays actually work against COVID-19? There has been quite a lot of activities in the COVID nasal spray space. Below, we look at some of the best nasal sprays for COVID-19 and summaries of the rationale and evidence for each category. Do note that some of them are available as an over-the-counter medication but some are still under clinical trial stage. McCullough Protocol 2022 Best Nasal Sprays for COVID-19 (2023) There are lots of great nasal sprays out there, and this list is by no means complete. We’ve included nasal sprays with proven anti-COVID-19 ingredient, you can buy over the counter or online. 1. Povidone Iodine Nasal Spray and COVID-19 Povidone iodine (PVP-I
Comments
Post a Comment